Purpose: Breast cancer cells abnormally express arginine vasopressin hormone (AVP) and its receptors. Clathrin-mediated endocytosis (CME) involves a machinery of intracellular endocytic proteins, including large Dynamins. The impact of Dynamin inhibition on the survivability and metastasis of triple-negative breast cancer cells, stimulated by AVP, was not well addressed. Methods: To explore this, Dynamin 2 was selectively inhibited by dynasore (DYN) in MDA MB-231 cells, which was prestimulated with AVP, or cotreated with, a PI3K/AKT/mTOR inhibitor. Results: Dynasore induced apoptosis in 19.2±1.5% of cells, whereas in cells transiently prestimulated with AVP or co-treated with Wortmannin (Wort), apoptosis has increased to 28.0±1.4% and 35.4±1.5%, respectively. This was associated with an increase in the expression of the autophagy indicators (LC3II protein and Beclin-1 mRNA), whereas, Wort reduced both markers. Moreover, 85.1%, 76.3% and 74.8% of cells were arrested in G0/G1 phase, when they were exposed to AVP, DYN or both, respectively. The Phosphorylated Akt (pAkt) decreased in DYN-treated cells in presence of AVP, Wort or both. Besides, DYN enhanced the expression of Bax and Caspase-3 genes, downregulated the multidrug resistance gene (MDR1), and reduced cell’s invasion. Conclusion: These results suggest the antineoplastic, anti-metastasis effects of Dynamin inhibition in triple negative breast cancer cells, in which V2R receptor was stimulated with AVP. Mechanistically, the drug repressed AKT/PI3K pathway, upregulated the apoptosis related genes and enhanced cells responsive to chemotherapy as similar as Wort. These events may nominate dynamin as anticancer target in breast cancer.